Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution... – Containing or obtained from hypericum
Reexamination Certificate
2008-11-18
2011-11-29
Mi, Qiuwen (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
Containing or obtained from hypericum
C424S736000
Reexamination Certificate
active
08067042
ABSTRACT:
Disclosed herein is a method of using megestrol acetate. In one embodiment, the method comprises informing a user that megestrol acetate is metabolized by a cytochrome p450 isozyme. In another embodiment, the method comprises obtaining megestrol acetate from a container associated with published material providing information is metabolized by a cytochrome p450 isozyme. Also disclosed are articles of manufacture comprising a container containing a dosage form of megestrol acetate, wherein the container is associated with published material informing that megestrol acetate is metabolized by a cytochrome p450 isozyme, a method of treatment, and a method of manufacturing a megestrol acetate product.
REFERENCES:
patent: 4760053 (1988-07-01), Labrie
patent: 2003/0108484 (2003-06-01), Leyland-Jones
Zhang et al, Screening study of the inhibitory effects 17 steroides on 6 major cytochrome p450 isoenzymes, Drug metabolism reviews 92006) 38 (3): 99-100.
Kornblith et al, Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer, Journal of Clinical Oncology, 11 (11), 1993: 2081-2089.
Williams et al, Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone, Science (New York, N.Y.), (Jul. 30, 2004) vol. 305, No. 5684, pp. 683-686.
Introduction of Megestrol acetate from Wikipedia, accessed on Nov. 13, 2010, pp. 1-2.
Nelson, David R. et al., “P450 Superfamily: Update on New Sequences, Gene Mapping, Accession Numbers and Nomenclature”; Pharmacogenetics; vol. 6; 1996; pp. 1-42.
“Drug Interaction Studies—Study Design, Data Analysis, and Implications for Dosing and Labeling; Preliminary Concept Paper”; Oct. 1, 2004; available @ http://www.fda.gov/ohrms/dockets/ac/04/briefing/2004-4079B1—04—Topic2-TabA.pdf.
Cantor & Colburn LLP
Mi Qiuwen
Mutual Pharmaceutical Company, Inc.
LandOfFree
Megestrol acetate products, method of manufacture, and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Megestrol acetate products, method of manufacture, and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Megestrol acetate products, method of manufacture, and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4289682